ABT•benzinga•
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty
Summary
Abbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 16, 2025 by benzinga